Compare Fastly Inc (FSLY) vs Eli Lilly And Co (LLY) Price & Performance

Fastly IncTrade

Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Fastly Inc vs Eli Lilly And Co — how do they compare? Fastly Inc trades at $20.63 (market cap $3.13B), while Eli Lilly And Co trades at $1,177.12 (market cap $1.03T). The key difference: Eli Lilly And Co is far larger — about 329.1× Fastly Inc's market cap, and Eli Lilly And Co pays a 0.6% dividend while Fastly Inc pays none. Which is the better fit depends on your goals.

	FSLY	LLY
Market Cap	$3.13B	$1.03T
Sector	Technology	Health
52-Week High	$33.50	$1.24K
52-Week Low	$6.36	$625.65
Enterprise Value	$3.20B	$1.07T
Dividend Yield	—	0.6%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fastly Inc

Fastly (FSLY) trades at $20.90, up 4.34% today, showing strong momentum after three consecutive quarterly earnings beats. The stock maintains a bullish technical signal with positive moving averages and trades near key resistance at $21-$22. Revenue growth continues at 20% year-over-year, though the company remains unprofitable with a -15.79% net margin. Recent news highlights strategic partnerships in edge computing and AI infrastructure development.

Despite consistent revenue growth and improving margins, Fastly faces profitability challenges with negative ROE and cash flow volatility. Analyst consensus is mixed with 29% buy ratings but a $24.25 price target suggesting 16% upside. Key risks include competitive pressure from larger cloud providers and the company's ability to achieve sustainable profitability amid heavy infrastructure investments.

Eli Lilly And Co

LLY trades at $1,154.27, down 2.6% today, amid a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q1 2026 EPS of $8.55 surpassing the $6.97 forecast. Revenue surged to $65.18B in 2025, driving a net income margin of 34.99%. Recent news includes the acquisition of AtaiBeckley for $2.8 billion, expanding its neuroscience pipeline.

Outlook remains positive with a consensus price target of $1,380, though high valuation multiples (P/E 41.09) and competitive pressures in obesity drugs present risks. Analyst sentiment is strongly bullish (73% buy ratings), supporting further upside if execution continues.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

FSLY

Fastly stock shows bullish momentum ahead of August earnings, with key support at $17 and resistance at $22.Seeking Alpha · 22 hours agoBullish View details →

LLY

Lilly to acquire AtaiBeckley for up to $3.8B, boosting its mental health drug pipelineProactive Investors · 5 hours agoBullish Eli Lilly to buy psychedelic drugmaker AtaiBeckley for $2.8B to boost mental health drug pipelineCNBC · 7 hours agoBullish Eli Lilly stock could grow 76% in 3 years driven by blockbuster drugs and new sales channels.Forbes · 2 days agoBullish View details →

About Fastly Inc

Fastly operates a content delivery network, which is necessary for entities to provide faster and more reliable online content. Fastly's strategy differs from traditional CDNs, which focused on locating servers in as many locations as possible to store copies of files that consumers most use. Fastly has far fewer sites than traditional CDNs, but it houses servers in the most network-dense data centers. Instead of simply storing static content, it allows its customers to program on its platform, enabling edge computing and better service of the more dynamic content that was traditionally not well served by CDNs. Fastly gears its service to the largest, most sophisticated enterprises rather than small companies and generated about two thirds of its revenue in the United States in 2020.